Drug Type Small molecule drug |
Synonyms AC 5216, AC-5216, SX-5216 + [2] |
Target |
Mechanism TSPO stimulants(Translocator protein stimulants) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC23H23N5O2 |
InChIKeyNBMBIEOUVBHEBM-UHFFFAOYSA-N |
CAS Registry226954-04-7 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Generalized anxiety disorder | Phase 2 | US | 01 Mar 2005 | |
Generalized anxiety disorder | Phase 2 | CA | 01 Mar 2005 | |
Anxiety | Phase 2 | - | - | |
Anxiety | Phase 2 | - | - | |
Anxiety Disorders | Phase 2 | US | - | |
Anxiety Disorders | Phase 2 | JP | - | - |
Anxiety Disorders | Phase 2 | CA | - | |
Depressive Disorder | Phase 2 | - | - | |
Depressive Disorder | Phase 2 | - | - | |
Depressive Disorder, Major | Phase 2 | US | - | - |